Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 196 AL 210

Further data to address the Alzheimer's coverage with evidence development questions

Boustani M, Klein EG, Zimmer JA, Wang H, Engle SE, Phipps A, Japha M, Schilling T, Hartry A; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2026 Aug;22(8):e71724. doi: 10.1002/alz.71724.

Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review

Brimson S, Thitilertdecha P, Kumaree KK, Brimson JM.

CNS Drugs. 2026 Sep;40(9):1225-1241. doi: 10.1007/s40263-026-01327-3. Epub 2026 Aug 6.

Discovery of Anti-Neuroinflammatory Compounds in Alzheimer's Disease: Current Trends and Future Perspectives

Paelaong N, Sripha K, Boondam Y.

Mol Neurobiol. 2026 Aug 8;63(1):819. doi: 10.1007/s12035-026-06114-1.

GLP-1 receptor agonists, metabolic syndrome, and Alzheimer's disease: Lessons and opportunities from the EVOKE trials

Gupta P, Pozzilli V, De Giovanni A, Sapio E, Motolese F, Capone F, Pozzilli P.

J Neuroendocrinol. 2026 Aug;38(8):e70246. doi: 10.1111/jne.70246.

Vitamin D and L-Cysteine as Potential Regulators of Adiponectin in Alzheimer's Disease: A Narrative Review

Justin Margret J, Jain SK.

Nutrients. 2026 Jul 26;18(15):2440. doi: 10.3390/nu18152440.

Pharmacological Effects and Molecular Mechanisms of Lignans in the Treatment of Alzheimer's Disease

Sun L, Zhu X, Fan C, Wang Y, Chen Q, Zhang L, Zhang Y, Liu Y.

Molecules. 2026 Jul 24;31(15):2594. doi: 10.3390/molecules31152594.

Distinct roles of AMPA receptor subunits as potential therapeutic targets in Alzheimer's disease

Seo J, Kim K, Park M.

Pharmacol Res. 2026 Sep;231:108394. doi: 10.1016/j.phrs.2026.108394. Epub 2026 Aug 13.

Unravelling the phytochemical complexity of neuroprotective plants: a metabolomics approach to Alzheimer's disease

Raj SN, Natnan ME, Lou WP, Mediani A, Tencomnao T, Baharum SN.

Mol Biol Rep. 2026 Aug 14;53(1):1403. doi: 10.1007/s11033-026-12565-5.

Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis

Javed MN, Khan SM, Mustafa S, Mujtaba A, Amin H, Azhar N, Hameed A, Zayed A, Khalid M, Hussain JM.

Brain Behav. 2026 Aug;16(8):e71643. doi: 10.1002/brb3.71643.

GLP-1 receptor agonists for Alzheimer's disease: Lessons from trials and translational challenges

Stringhi R, Padovani A, Marcello E.

Cell Rep Med. 2026 Aug 18;7(8):102918. doi: 10.1016/j.xcrm.2026.102918.

Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease

Bernath MM, Brosch J, Saykin AJ, Wilcock D, Summanwar D, Willis DR.

Alzheimers Dement. 2026 Aug;22(8):e71769. doi: 10.1002/alz.71769.

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease

Budson AE, Ljubenkov PA, Ritter A, Leahy C, Ramanan VK, Brosch J, Burke A, Matthews BR.

Front Neurol. 2026 Aug 10;17:1863897. doi: 10.3389/fneur.2026.1863897. eCollection 2026.

Estimating treatment effects in clinical studies of Alzheimer's disease: What are estimands and why do we need them?

Hendrix S, Mallinckrodt C, Abschneider RM, Atri A, Bendtsen MD, Colombo TL, Feldman HH, Johannsen P, Cummings J.

Alzheimers Dement. 2026 Aug;22(8):e71676. doi: 10.1002/alz.71676.

Advances in Alzheimer's disease: mechanistic insights and therapeutic targets

Jia YJ, Ge YJ, Li B, Yang Y, Chen H, Liu J, Guo JH, Yu JT, Ye KQ, Wang JZ, Song W, Wang YJ.

Sci China Life Sci. 2026 Aug;69(8):2543-2574. doi: 10.1007/s11427-025-2991-7. Epub 2026 Jan 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias